Mainz, Federal Republic of Germany. The target antigen of human autoantibodies to glomerular basement membrane in Goodpasture's (GP) syndrome is localized on the non-collagenous globular domain NC1 of collagen IV. It was the aim of this investigation to demonstrate the OP antigen in basement membranes preparations from various tissues. Collagenase-digested basement membrane preparations from human kidney glomeruli (GBM) and tubules (TBM), lung (LBM), chorioid plexus (PxBM), aorta (ABM), intestine (IBM), and placenta (PBM) were analyzed according to their reactivity to antiglomerular basement membrane (anti-GBM) antibody-positive OP sera, Sodiumdodecyl-sulfate polyacryl gel electrophoresis and immunoblotting was performed after antigen enrichment by passage of the collagenase digests through an anion exchange column. The relative amounts of the antigens were estimated by inhibition-ELISA. Reactivity of anti-GBM antibodies with one to three monomers (24 to 28 kD) and two dimers (44 kD, 50 kD) could be demonstrated in basement membrane preparations of kidney glomeruli, kidney tubules, lung, placenta, and aorta. In basement membranes of chorioid plexus reactivity with the 28 kD monomer and the 50 kD dimer, in intestinal basement membrane reactivity with the 50 kD dimer could only be shown. Analysis of the relative amounts of GP antigen by inhibition-ELISA demonstrated highest concentrations in GBM and and lower in the other basement membranes (TBM > PxBM > IBM > PBM > LBM > ABM). The results indicate, that OP antigens are common to all basement membranes investigated. The differences in antigen concentration and in reactivity on immunoblotting may indicate different relative amounts, differences in the degree of cross linking of monomers into dimers, or a heterogeneity of collagen IV within the various basement membranes. The clinical manifestation of the anti-GBM disease is therefore not explained by a restriction of the antigen to basement membranes of lungs and kidneys but may be influenced by the differences described here, a variable accessability of the antigen, as well as by nonimmunologic mechanisms.
Regulation of cell volume in proximal renal tubules. F. Lang, H. Völkl, Institute for Physiology, University of A 6010 Innsbruck, Austria.
Transcellular sodium reabsorption in proximal renal tubules exceeds intracellular sodium pool within less than a minute. An imbalance of sodium entry across the luminal cell membrane and sodium extrusion across the basolateral cell membrane thus results in rapid alterations of intracellular sodium activity and cell volume, It is not surprising, therefore, that proximal tubule cells are provided with volume regulatory mechanisms. In order to elucidate those mechanisms, isolated perfused straight proximal renal tubules were exposed to hypotonic bath perfusates and cell volume determined from serial photographs. Replacement of 40 mmollliter NaCI in the bath with 80 mmollliter mannitol did not appreciably alter cell volume. Reduction of bath The stimulation of transport is in part due to activation of potassium channels in the basolateral cell membrane, present in both, confluent and subconfluent MDCK cells. The present study has been designed to further define the effect of epinephrine. To this end cell membrane potential was continuously traced in subconfluent MDCK-cells before and during application of epinephrine and/or clonidine. Epinephrine (1 smol/liter) lead to a sustained hyperpolarization from -51 1 mV to -71
I mY (N = 31), paralleled by a decrease of the resistance and an increase of the potassium selectivity of the cell membrane. The hyperpolarising effect of epinephrine was due to activation of potassium channels. The effect was completely abolished by phentolamine and is thus mediated by a-receptors. Activation of /3-receptors lead to a shallow depolarization due to activation of chloride channels. In cells pretreated with pertussis-toxin the effect was only transient; the sustained hyperpolarization was thus probably mediated by pertussis-toxin sensitive GTP-binding proteins (0-proteins). Clonidine (100 nmollliter) lead to a transient hyperpolarization of the cell membrane by -11 I mV (N = 33). Half-maximal effects required 20 nmollliter. The effect of clonidine was abolished by 10 nmollliter yohimbine, and was probably mediated by a2-receptors. In the presence of 10 nmol/liter clonidine the effect of epinephrine is only transient. Thus, clonidine exerted an anti-a-adrenergic action in MDCK cells, possibly via imidazole receptors, which have recently been identified in renal tissue.
Effects of prostaglandin E1 (PGE1) on postischemic acute renal ischemia. G. Torsello, P. Reinecke, B. Kutkuhn, Z. Szabo, B. Grabensee, Departments of Vascular Surgery and Renal Transplantation, Pathology, Nephrology, and Nuclear Medicine, University of Düsseldorf, Federal Republic of Germany. The incidence of acute renal failure after suprarenal aortic surgery and renal artery reconstruction has been reported to be as high as 30%, Because preservation of kidney function can play an important role in the morbidity and mortality of these patients, the effects of preischemic infusion of POE1 (100 ng/kg/min) were studied in a canine model. In 20 mongrel dogs plasma creatinine blood, urea nitrogen, osmolal, free-water and creatinine clearance as well as renal blood flow and renovascular resistance were measured before and after clamping of supra and infrarenal aorta, as well as both renal arteries for a three hours period. The dogs were followed up for two weeks and radionuclide studies with Tc-99m-Mag3, I-131-OIH and In-I 13m-DTPA were performed on third postoperative day. Two weeks postoperatively the animals were sacrificed and the kidneys removed for histologic examination. The results of both groups (POE1 N = 10; NaCl 0.9% N = 10) were studied using statistical analysis of variance procedures for repeated measurements. After renal ischemia 9 dogs of the control group and 3 dogs of the PGE1-group developed acute renal failure (P < 0.05). POE1 infusion significantly attenuated the postischemic fall in glomerular filtration rate, and renal concentrating ability as well as the postischemic increase of plasma creatinine and blood urea nitrogen induced by three hours warm renal ischemia (P < 0.05).
Radionuclide studies showed a significant preservation of DTPA clearance and extraction fraction of MAG3 and DTPA in the POE1 group. The transit times for Hippuran and MAG3 were significant shorter. The effects of preischemic infusion of PGE1 on hemodynamic parameters as renal blood flow and renal vascular resistance were evident but the difference was not statistically significant. After perfusion fixation 18 kidneys were examined by light microscopy. Five of 9 animals pretreated with POEI showed no important changes. Three of them showed tubular dilation, only one had severe necrosis of renal cortex. In 9 animals treated with saline solution no changes were found in two and dilated canaliculi in one dog. In 6 animals there were partly necroses covered with small spots of renal cortex, partly extended necrosis of renal cortex. The morphological findings showed a good correlation with the clinical and laboratory data. The results show that the preischemic POEI infusion significantly influenced both incidence and severity of postischemic renal failure and suggest that the protective mechanism of POEI on postischemic renal function is not only a consequence of vasodilation but is mainly due to a cytoprotective effect of the substance. Future clinical experience and a randomized prospective study will show the value of this substance as a vasodilator in the preclamping phase and for preservation of renal and spinal function after suprarenal surgery.
Antibody-independent unilateral glomerular lesions induced by cobra venom factor (CVF). R. Metz, M. Zeier, J. Nitsch, M. Raghunath, E. Ritz, E. W. Rauterberg, Institute of Immunology and Department of Internal Medicine, Heidelberg, Federal Republic of Germany, Glomerular deposits of complement (C) components are found in the majority of patients with glomerulonephritis, but the relative contribution of local C-activation to glomerular lesions is unknown. We developed an unilateral antibody-independent model of glomerular injury in rats using the contralateral kidney as control. A bolus of highly purified CVF from Naja naja khaoutia, a potent activator of the alternative C-pathway, was administered via the right suprarenal artery. Trapping of CVF was enhanced by a preceding bolus injection of concanavalin A (ConA). Controls received saline or ConA alone. Animals were sacrificed 2 hours or 3 days after injection. Cryostate sections of the left (untreated) and right kidney were examined by histology and immunohistochemistry (monoclonal antibodies against rat granulocytes or MØ). Fifty micrograms CVF alone caused no and 200 g ConA only marginal effects. In contrast, 50 ig CVF, preceded by 500 g ConA, caused enlargement of glomerular diameters after 2 hours (treated vs. untreated kidney P < 0.0007). In parallel, the numbers of cells (counted as nuclei per glomerulus) were increased as was the number of granulocytes per glomerulus (22 + 5.8 vs. 14 + 4.3; P <0.0001). Administration of saline gave consistently negative results. Despite the high accumulation of inflammatory cells in the glomeruli, no significant proteinuria or albuminuria was present. In vivo binding of ConA and CVF to glomerular sites was shown by immunohistochemistry. We conclude that (1) CVF provokes glomerular lesions in the absence of antibodies and (2) the CVF model is suitable to further elucidate the contribution of activated C-products to the induction of glomerular injury.
Studies on the excretion of structural proteins, and of the influence of non-enzymatically glycosylated serum proteins in diabetic nephropathy. (Brownlee et al., N EnglJ Med 318:1315 -1321 , 1987 . Here the question arises whether development and progression of diabetic nephropathy is (i) influenced by modified serum proteins and (ii) detectable by the renal excretion of structural proteins. Results: (i) The ratio of glycated albumin was increased in serum (5-fold) and urine (2.5-fold) of diabetics (N = 25) . A difference between patients with and without albuminuria (N = 9,363 mg/12 hr vs. N = 11,23 mg/l2 hr; controls N = 13, 13 mg/12 hr) could not be detected. The fraction of glycated albumin was exclusively anionic. There was no cationized albumin. (ii) The concentration of fibronectin (ELISA) in serum of diabetics was increased (a < 0.01). The urinary excretion of fibronectin was increased as well (a < 0.001). The diabetic patients also excreted lower amounts of TammHorsfall protein (THP) (a < 0.05). Conclusions. The increase of non-enzymatically glycated albumin could explain microalbuminuna in early stage of diabetes. The increase in the urinary excretion of fibronectin, and the reduction in THP-excretion is an early marker of the renal involvement in diabetes.
Cell to cell coupling at the afferent arteriole: a combined electrophysiological and morphological study. R. Nobiling, C.P. Bührle, I. Physiologisches Institut der Universitat Heidelberg Im Neuenheimer Feld 326, 69 Heidelberg, Federal Republic of Germany. The transmission of acute and chronic stimuli along the afferent arteriole in the context of autoregulation of renal blood flow or control of renin release is frequently discussed by assuming this arteriole to be a single unit vessel. It is, however, not clear whether or not gap junctions, as observed at the vascular pole close to the glomerulus, are present along the entire vessel. Therefore, we investigated this problem using simultaneous intracellular recordings from two cells and electron microscopy. Owing to the inaccessibility of this vascular region in the intact kidney, the electrophysiological part of the study was performed with hydronephrotic mouse kidneys. Simultanuous intracellular recordings revealed a length constant of 20 j.tm or less, indicating that-if any-less than three cells are coupled. These measurements were supported by a virtual lack of gap junctions between the smooth muscle cells in this arteriole. These observations were made by electron microscopy of freeze fracture replicas and thin sections of normal and hydrophrotic kidneys of mice and rats. Additionally, the rich innervation of the afferent arteriole, as demonstrated by both catecholamine fluorescence and electron microscopy, suggests that the vessel can also be described morphologically as a multi-unit vessel. As a consequence, functional aspects concerning the control of renin secretion or autoregulation of renal plasma flow are to be reconsidered.
Treatment of hypertensive heart disease. W. Motz, B.E. Strauer, University of Duesseldorf, Department of Medicine, Moorensir. 5, D-4000 Düsseldorf I, Federal Republic of Germany. Epidemiologic studies have shown that arterial hypertension resembles the most serious risk factor for the development of heart failure. The incidence of heart failure was ten times increased in patients with both arterial hypertension und electrocardiographic signs of left ventricular hypertrophy than in patients with arterial hypertension without hypertrophy. Consequently, reversal or prevention of the development of myocardial hypertrophy is an important aim in the treatment of arterial hypertension to prevent heart failure. Experimental studies have shown that an antihypertensive treatment does not automatically reverse left ventricular hypertrophy. For example, vasodilators of the hydralazine-type do not reverse hypertrophy or even increase left ventricular myocardial mass despite blood pressure normalization. Accordingly, we asked the question whether an antihypertensive treatment under clinical conditions with widely used antihypertensive drugs such as diuretics, ACEinhibitors, calcium-channel blockers or sympatholytic drugs can regress hypertrophy in hypertensive patients under clinical conditions. After a 12 month long treatment with enalapril, nifedipine, nitrendipine and clonidine, regression of left ventricular hypertrophy was obtained along with blood pressure normalization. An antihypertensive treatment with the diuretic hydrochlorothiazid in combination with triamteren could not bring about reversal of hypertrophy parallel with blood pressure reduction. Reversal of hypertrophy in relation to blood pressure reduction was found to be most pronounced after treatment with the sympathicolytic drug clonidine. This finding favors the hypothesis that catecholamines play an important part in determining progression and regression of left ventricular hypertrophy. Accordingly, patients with hypertensive hypertrophy should be treated with drugs such as clonidine, enalapril or nifedipine and nitrendipine rather than with diuretics. Whether the prognosis of patients with hypertensive hypertrophy can be improved by reversal of hypertrophy also cannot be answered at the moment and remains subject of future research. (Virchows Archiv 1975 , 1977 , a cooperative multicenter study was initiated in 1978 with 16 pediatric departments participating. It has been the aim of this (ongoing) study to obtain long-term follow-up data of old and new patients in order to determine whether there are clinical and immunological differences related to the fine structural subclassification of 3 types of deposit formation. The diagnosis of idiopathic MPGN was established in 50 children, 27 girls and 23 boys aged 4 to 14 (median: 9.5) years.
They entered the study with a known duration of the disease of 2 months to 10 years (median: 2 years). Electron microscopy including silver impregnation of ultrathin sections for the distinction of type 3 revealed the typical lesion of type 1 in 27, type 2 in 16, and type 3 in 7 patients. Most frequently the presenting clinical feature at apparent onset of the disease was the nephrotic syndrome in type 1, gross hematuria in type 2, and the chance of finding urinary abnormalities in the absence of clinical symptoms in type 3. Persisting aminonucleosis nephrosis (AN) in rats of the Milan normotensive strain (MNS) and not in rats of the Milan hypertensive strain (MHS). V. Kliem, K. Kuhn, H. Claus, K.M. Koch, E. Reale, Division of Nephrology, Department of Internal Medicine and Laboratory of Electronmicroscopy, Hanover Medical School, Hanover, Federal Republic of Germany. We have recently shown that rats of MNS, beginning at the age of six months, will spontaneously develop progressive glomerulosclerosis (GS) and proteinuria (PU), while MHS rats, despite an increased arterial blood pressure (BP), will remain almost unaffected. The spontaneous morphological lesions involve glomerular epithelial changes with blabs. We have now investigated whether the course of experimental induced AN in MNS rats differs from AN in MHS rats. Experiments were performed on 8 MNS and MHS rats each (age: three months). At this age, MNS rats had a higher PU than MHS rats (103 87 vs. 29 4 mg/24 hr, P <0.01). GS, however, had not yet developed in MNS rats. Each animal received a single i.p. injection of 9 mg/l00 mg body weight of puromycin aminonucleoside (PAN). On days 5, 12, 26, and 42 after the injection, serum creatinine and PU were measured. On day 42 the kidneys were fixed by perfusion for light and electron microscopy. As early as the 5th day of AN, both MNS and MHS rats suffered from significantly increased PU (804 330 vs. 837 119 mg/24 hr on day 12). PU decreased in MHS rats from 413 104 mg/24 hr on day 26 to 136 65 mg/24 hr on day 42. In MNS rats, however, PU remained on the same level (956 399 mg/24 hr on day 26, 868 336 mg/24 hr on day 42). Serum creatinine did not differ significantly in MNS and MHS rats. In MNS rats suffering from AN glomerular epithelial changes were more pronounced than in MHS rats.
In addition, intratubular protein casts and interstitial cellular infiltrations were more numerous. GS, incomplete or fully developed, was observed in 40 to 50% of the glomeruli in MNS rats in contrast to 10 to 15% of the glomeruli in MHS rats. Summary: A single injection of PAN induced a persisting AN in MNS rats in contrast to MHS rats (observations period: 42 days). These data indicate that, independent of systemic arterial BP, MNS rats-and not MHS rats-are genetically predisposed to develop spontaneous glomerular epithelial lesions. This susceptibility is potentiated by PAN and results in premature and persisting GS and PU.
Evidence of specific insulin receptors on plasma membranes isolated from proximal tubule epithelia of human kidney. J.E. Scherberich, S.
Zeuzem, G. Wolf, W. Schoeppe, Dept. Nephrology and Department Endocrinology, University Hospital, D-6000 Frankfurt am Main, Federal Republic of Germany. After passing the glomerular filter, insulin, as concluded from experimental animal studies, is further handled by the tubule through a luminal endocytotic pathway. In contrast to glucagon, insulin (or the insulin-receptor complex) is incorporated into the cytoplasmatic compartment and then subsequently split by lysosomal proteases. Since specific transport mechanisms may exist for different peptides/peptide hormones, we were interested in elucidating if whether or not the luminal plasma membrane (PM) of the proximal tubule of the normal human kidney exhibits binding sites specific for insulin of human origin. Brush border fragments were isolated from tissue homogenates of renal cortex by differential centrifugation and sucrose density gradient centrifugation; rise of specific marker enzymes such as alkaline phosphatase, ala-(leu-, gly-) aminopeptidase and yglutamyl-transpeptidase as well as ultrastructural criteria were used monitoring the enrichment of PM. PM were incubated with monoiodinated 125-J-(Tyr-A 14)-human insulin (specific activity 330 s Ci/sg) at 4°C: as calculated from the association kinetics of the insulin binding curve, steady state conditions were reached after 48 hours. Incubation of PM with 125-J-(Tyr-A 14) human insulin and increasing concentrations of native insulin at 4°C resulted in competitive inhibition of 125-J-insulin binding. The maximum of specific insulin binding (tracer concentration 10 pmol/liter)-corrected for degradation-was 6.9 2.l%/I00 mg PM-protein; nonspecific binding averaged less than oneforth (12.6 + 4.4%, N = 4) of the total radioactivity bound (100%). The degradation rate of native human insulin was 17. Effect of diltiazem and allopurinol on kidney microcirculation in postischemic ARF. A. Pethö, W. Mielke, F. Vetterlein, G. Schmidt, Zentrum Pharmakologie und Toxikologie, Georg-August-Universitat Gottingen, Federal Republic of Germany. Alterations of kidney microcirculation were studied in anaesthetized rats subjected to 60 mm of unilateral renal ischemia followed by a 60 mm reflow. Capillary plasma flow distribution was determined by injecting two different fluorochrome-labeled globulins 1 and 3 mm prior to rapid freezing of the kidney. Histological evaluation of the untreated ischemic kidneys revealed extensive perfusion defects mainly in the outer medulla (47.8% of randomly-selected tissue points were more than 60 sm distant to the next perfused capillary vs. 0% in the control kidneys). Intravenous administration of diltiazem during the pre-and postischemic period (1.6 mgIlOO g body wt) and maintenance of the rats on allopurinol-saturated drinking water for six days prior to the experiments (approx. 5 mg allopurinol/lOO g body wt/day), respectively, significantly ameliorated postischemic outer medullary microperfusion (15.7% and 17.9% of tissue points more than 60 sm distant to the next perfused capillary, respectively). Combination of these two treatment procedures resulted in an almost complete normalization of capillary reperfusion pattern (1.3% of tissue points more than 60 m distant to the next perfused capillary). Thus, both the Ca2-antagonist diltiazem and the xanthineoxidase inhibitor allopurinol were clearly effective in reducing postischemic alterations of kidney microcirculation. Furthermore, combination of the two drugs even led to an almost complete restoration of capillary perfusion pattern.
Renal action of atrial natriuretic peptide (ANP) is reduced by ACEinhibition. G. Wambach, U. Schittenhelm, M. Stimpel, G. Bbnner, W. Kaufmann, Medizinische Klinik II der Universitat KOIn, Ostmerheimerstr.200, D-5000 Koln 91, Federal Republic of Germany. Due to its pharmacological action on renal, adrenal and vascular tissue, ANP is considered as a physiological antagonist of the renin-angiotensinaldosterone-system (RAAS). However, the interactions of the sodium retaining RAAS and the natriuretic ANP are only partially understood. We therefore studied the acute cardiovascular and renal action of ANP (0.1 1kg/kg body wt over 30 mm) in 10 normal subjects (6m/4f, 31 to 51 years) during a control period (A) and after inhibition of the angiotensin converting enzyme (B) with enalapril (2.5 mg tid). Urine output, urinary Na', K, cyclic GMP, glomerular filtration rate (GFR), arterial blood pressure (BP) and heart rate were tested during 90 mm before, during and 90 mm after the infusion of ANP ( 5EM During the control infusion of ANP, urinary volume, Na excretion and cGMP excretion increased significantly. After ACE inhibition, stimulation of urinary Na output and urinary volume was blunted, the rise in cGMP remained unchanged. GFR averaged 127 ± IS mI/mm during ANP infusion. After ACE inhibition GFR was slightly lowered to 117 ± 19 mI/mm, however the stimulation by ANP was maintained with a mean of 137 ± 19 mI/mm. Systolic BP was reduced from 112 ± 3 to 106 ± 3 mm Hg and diastolic BP from 71 ± 2 to 66 ± 3 mm Hg during ANP infusion. After ACE inhibition, control BP was lowered to 101 ± 3 over 63 ± 2 mm Hg. ANP led to additional reduction to 95 ± 3 over 59 ± 2 collecting duct cells effects an increase of Na transport. Three different theories exist for the biochemical mechanism that the increase of Na-transport may be triggered: 1) by an opening of apical sodium channels; 2) by the induction of aldosterone induced proteins (AlPs; such as, Na/K-ATPase); and 3) by an activation of ATP-delivering enzymes of the mitochondrial pathway. ATP, an energy rich molecule, is preferably generated by the tricarboxylic acid cycle and by oxidative phosphorylation. This mechanism seems to be accelerated by increased citrate synthase activity. Consequently, we investigated the activity of citrate synthase after acute aldosterone application on cultured renal collecting duct epithelium, The experiments demonstrated that aldosterone indeed has an influence on citrate synthase activity in cultured collecting duct cells. While controls showed basal values of 71 3 mU/mg protein (N, 28), hormone treated epithelia had increased citrate synthase activity of 79 6 mU/mg after 1 hour (N, 5), 88 6 mU/mg after 2 hours (N, 6), and 93 8 mU/mg protein after 3 hours (N, 5) of administration (P < 0.05 paired t-test). After that period, the activity during the 4th and 6th hour was found to be decreased to basal values. The significant 30% increase in citrate synthase enzyme activity within 3 hours could be blocked by spironolactone. Regarding the time course of enzyme stimulation, the results indicated that aldosterone activates citrate synthase during the physiological early response phase. Radioactive labelling experiments further showed that hormone stimulated increase of citrate synthesis activity seems to be related to an activation of preformed molecules, and not to a new synthesis of citrate synthesis. [1970] [1971] [1972] [1973] [1974] [1975] [1976] [1977] [1978] [1979] [1980] [1981] [1982] [1983] [1984] [1985] [1986] ) with a mean observation time of five years (±45 months). Most of the 46 patients had idiopathic RPGN (61%). Initially, hemodialysis needed 25 of the 46 patients (54%). Immunosuppressive therapy (plasma exchange, methylprednisolone pulses, steroids, cyclophosphamide, azathioprine) was administered in 36 of the 46 patients (78%). A remission was achieved in only 19 of the 36 patients who received immunosuppression (53%) and no spontaneous improvement was seen. Factors indicating poor prognosis were initial serum creatinine, percent of crescents in glomeruli, glomerular sclerosis, and immunohistologic staining of the IgG at the tubuli. In II patients with remission, immunosuppression was discontinued and 6 had a relapse. Long-term immunosuppression was given to 8 patients with remission. Their renal function was not normal (creatinine 240 77 mol/liter), but none had a relapse (P = 0.01). It is concluded that the treatment of RPGN requires long-term attendance and repeated immunosuppression comparable to a systemic immune disease. fixation of MCA-Pl along the GBMs, Bowman's capsule as well as distal tubular and collecting duct basement membranes. In 11 renal biopsies, no binding of MCA-P1 was detected. On EM, GBM splitting was present in 9 cases, 2 patients had isolated GBM thinning. Only 6 patients fulfilled strict diagnostic criteria of Alport's syndrome. In 8 patients, a reduced or discontinuous reactivity was observed (2 with GBM splitting, 4 with isolated GBM-thinning, 2 with non-specific GBM lesions). One patient had Alport's syndrome. Renal biopsies of 27 patients disclosed completely normal binding-as observed in all control specimens-of MCA-P1 along the GBMs and TBMs. Eleven of these patients were classified as having Alport's syndrome. No definite relationship was detected between the MCA-Pl binding pattern and the nature of the GBM lesions (splitting and thinning, isolated thinning) as well as the extent of GBM-splitting. Preincubation of sections with 6 M urea in glycine-HCI buffer (pH 3.5) did not change the MCA-Pl binding pattern. We conclude that only a subgroup of patients with Alport's syndrome/FH shows abnormal MCA-Pl reactivity which cannot be Conclusions: (1) The in situ perfused frog kidney is a suitable model for studying peritubular amino acid uptake. (2) In the amphibian kidney, a peritubular uptake mechanism for L-Cit exists, which is stereospecific, saturable, NaCI-dependent and can be inhibited by L-Phe. (3) In the tubule cells, L-Cit and L-Aspartate are transformed into Arg, which in turn is released into the venous outflow. (4) L-Cit is secreted into the urine to a small but significantly greater extent than D-Cit, proving that transcellular, carrier-mediated amino acid transport can in principle also run in the blood to lumen direction (=secretion). This transcellular pathway seems to be more important for the secretory amino acid leak than the paracellular pathway.
Influence of sympathetic nerves on renal autoregulation in conscious dogs. P. Persson, H. Ehmke, B. Nafz, H. Kirchheim, I. Physiologisches Institut der Universität Heidelberg, Federal Republic of Germany. The autoregulation of renal blood flow and glomerular filtration rate over a wide pressure range is essential for renal function. There are three characteristic features of autoregulation: (I) the level of blood flow and filtration rate in the autoregulatory pressure range; (2) the lower pressure limit of autoregulation; (3) the slope by which renal blood flow and glomerular filtration rate decrease beneath the lower limit of autoregulation. In 6 conscious foxhounds, a step-wise reduction of renal artery pressure was made to determine these autoregulation characteristics of renal blood flow (RBF) and glomerular filtration rate (GFR, table) . A moderate sympathetic activation via common carotid occlusion (CCO) shifted the lower limit of autoregulation by >15 mm Hg. This shift was reversed by an intrarenal a-blockade (Prazosin), but not by the All antagonist Saralasin. In addition the a-agonist Methoxamine had the same effect as CCO. We conclude that the autoregulation shift is mediated by a-adrenoceptors. Effect of a-and j'J-adrenergic and muscarinic antagonists on the rat renal Na/H exchanger. T. Friedrich, G. Burckhardt, Faculty of Medicine, Kyoto University, Kyoto 606, Japan, and Max-PlanckInstitut für Biophysik, Kennedyallee 70, D-6000 Frankfurt a.M., Fed. era! Republic of Germany. The renal Na/H exchanger located in the brush border membrane of proximal tubule cells is responsible for H secretion, and by that way regulates salt and water reabsorption. The exchanger is inhibited by amiloride, which is a competitive inhibitor of sodium. Amiloride also interacts with a-and /3-adrenergic receptors. This might be explained by structural similarities between the Na/H exchanger and G-protein coupled receptors. Our results show that the a-antagonist clonidine, the 13-antagonist propranolol and the antagonist of muscarinic acetylcholine receptors, propylbenzilyl-choline mustard, are potent inhibitors of the renal Na/H exchanger. Affinity labeling of the Na/H exchanger protein (molecular weight 65000) by ('4C)N, N'-dicyclohexylcarbodiimide (DCCD) is suppressed by Na, amiloride, a-and /3-antagonists. This result indicates an interaction between antagonists of adrenergic receptors and the Na binding site of the Na/H exchanger. We were also successful in labeling the Na/H exchanger by ('251)iodocyanopindolol-diazirine, a reagent for /3-receptors, and by (3H)propylbenzilylcholine mustard. Amiloride and propranolol protect from this labeling. We conclude that there might exist a molecular relationship between the Na/H exchanger and the family of G-protein related receptors.
